Ms. Anja Krammer
CEO of Turn. At 3:40, the bio talks about getting products to market faster than in a decade.
#ERA #sebastiano #turnbio #krammer #stanford #healthspan #aging #longevity.
Anja Krammer CEO of Turn Biotechnologies discusses the initial targets for ERA and the timeline for clinical trials.
Turn Bio, co-founded Dr. Vittorio Sebastiao, was created to commercialize the Epigenetic Reprogramming of Aging Technology that he developed in his Stanford University lab.
Ms. Krammer has worked for F500 companies in healthcare and technology and is the co-founder of 3 Silicon Valley start-ups. She has been an entrepreneur for over 20 years, assembling high-performance teams to build biotech, consumer and pharmaceutical businesses.
Turn Biotechnologies, Inc.
https://www.turn.bio/
Paper on ERA Technology
https://www.nature.com/articles/s41467-020-15174-3
Additional papers by Dr. Sebastiano
http://med.stanford.edu/sebastiano/publications.html
Source:
